[Management of toxicities due to anti-angiogenic treatment of metastatic renal carcinoma].

Abstract	Important advances have been achieved in the treatment of metastatic renal cell carcinoma in the last few years with the targeted therapy. The consequences on the physiological microvasculature could be at the origin of the adverse effects. It seems important for the clinician to know the physiopathology and the management of these toxicities.
Authors	A Méjean, T Lebret
Journal	Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie (Prog Urol) Vol. 18 Suppl 7 Pg. S315-9 (Nov 2008) ISSN: 1166-7087 [Print] France
Vernacular Title	Gestion des toxicités des traitements cibles dans le traitement du cancer du rein métastatique.
PMID	19070809 (Publication Type: English Abstract, Journal Article)
Chemical References	Angiogenesis Inhibitors
Topics	Angiogenesis Inhibitors (adverse effects) Carcinoma, Renal Cell (drug therapy, secondary) Humans Hypertension (chemically induced, therapy) Kidney Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!